Business Context and Reporting Period
This Form 8-K was filed by Jupiter Wellness, Inc. on December 14, 2021, reporting events beginning December 8, 2021. The request metadata identifies BONK, Inc., but the filing registrant is Jupiter Wellness, Inc. (Nasdaq: JUPW; warrants: JUPWW).
The filing announces a proposed acquisition of Next Frontier Pharmaceuticals, Inc. (NFP), under which Jupiter Wellness would acquire all outstanding NFP capital stock through a merger involving its wholly owned subsidiary, Jupiter Wellness Investments, Inc.
Key Financial and Capitalization Terms
| Item | Reported terms |
|---|---|
| Acquisition consideration | 500,000 newly designated Series B Preferred Stock shares, subject to customary adjustments for indebtedness and transaction expenses. |
| Potential common-stock issuance | Each preferred share is intended to be convertible into 130 common shares, or an aggregate of 65,000,000 common shares, subject to stockholder approval. |
| Preferred-stock liquidation preference | $234 per Series B Preferred Stock share. |
| Loan to NFP | $10.2 million secured promissory note issued to Jupiter Wellness; interest rate of 8% per year. |
| Loan maturity | Generally the earlier of six months after issuance, an event of default, December 31, 2021 if the merger agreement is not signed by then, or another date specified in the note. |
| Default interest and conversion | Following an event of default, interest increases to 15% per year, and Jupiter may convert principal and interest at a rate of 0.35% of NFP’s fully diluted common stock for each $100,000 converted. |
| Loan priority | The note is secured but subordinated to a $26.9 million senior lien and senior to other NFP indebtedness, subject to the applicable agreements. |
The filing does not provide revenue, net income, operating cash flow, cash balances, margins, or comparative-period financial results. It also does not clearly state Jupiter Wellness’s total debt or liquidity position as of the reporting date.
Material Changes Versus the Prior Comparable Period
- The filing describes a proposed acquisition and related financing; it does not present historical-period financial statements or quantified period-over-period operating changes.
- Jupiter Wellness agreed to issue securities potentially convertible into 65 million common shares, creating significant potential dilution.
- The company agreed to provide NFP with a $10.2 million secured loan and subordinate its related rights to specified senior debt.
- The company plans to sell subsidiary SRM Entertainment LTD to members of management for negotiated fair-value consideration at or around the acquisition closing.
- Existing management is expected to transition to part-time advisory roles for three years, with advisory fees, benefits, and potential bonuses.
Guidance, Outlook, Risks, Contingencies, and Unusual Items
- The acquisition had not closed as of the filing. Closing depends on customary conditions, including audits and reviews of NFP, an independent financial fairness opinion, board approval, stockholder approval, regulatory approvals, support agreements, advisory agreements, and completion of the proposed SRM transaction.
- Stockholder approval is required for conversion of the Series B Preferred Stock and potentially for an amendment authorizing enough common shares for conversion.
- Stockholders representing approximately 12% of common shares outstanding before the acquisition were expected to enter voting and support agreements favoring the conversion proposal.
- Sellers’ indemnification obligations are generally capped at 20% of the value of the Series B Preferred Stock, subject to the purchase agreement.
- The loan is exposed to credit, collateral, subordination, and default risk. Jupiter’s rights are subordinated to obligations owed to Benuvia Holdings under the senior financing documents.
- The filing contains customary forward-looking statement warnings, including risks related to transaction completion, financing, integration, regulatory matters, dilution, and the company’s other SEC-filed risk factors.
- The transaction was structured under an exemption from Securities Act registration, relying on Section 4(2) and/or Regulation D.
Important Facts for Investors to Verify
- Whether the acquisition ultimately closed and the final amount of consideration after indebtedness and transaction-expense adjustments.
- Whether stockholders approved the conversion proposal and any authorized-share amendment.
- The final number of common shares issued or issuable upon conversion and the resulting ownership dilution.
- NFP’s audited 2020 and reviewed nine-month 2021 financial results, which were closing conditions but are not included in the provided filing text.
- The status, collectability, collateral value, maturity, and senior-lien priority of the $10.2 million NFP note.
- Whether SRM Entertainment LTD was sold, the final negotiated consideration, and the effect on Jupiter Wellness’s operations and financial statements.
- The final terms and costs of management advisory agreements and any related-party implications.